Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. [electronic resource]
Producer: 20190610Description: 1504-1515 p. digitalISSN:- 1474-5488
- Adenocarcinoma -- mortality
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Canada
- Chemoradiotherapy -- adverse effects
- Dose Fractionation, Radiation
- Drug Administration Schedule
- Flutamide -- administration & dosage
- Goserelin -- administration & dosage
- Humans
- Kallikreins -- blood
- Leuprolide -- administration & dosage
- Male
- Neoplasm Grading
- Neoplasm Staging
- Progression-Free Survival
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- mortality
- Time Factors
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.